Skip to main content
. 2021 Nov 12;11:796839. doi: 10.3389/fonc.2021.796839

Figure 5.

Figure 5

siFBI-1 enhanced the sensitivity of MHCC97-H cells to sorafenib in a nude mice model. The MHCC97-H cells were transfected with vectors and injected into the nude mice to form the subcutaneous tumor models. The mice received the oral administration of 0.5 mg/kg Sorafenib. The results are shown as images (A) or the quantitative results (B–E). *p < 0.05.